Co-trimoxazole-induced erythema annulare centrifugum
DOI:
https://doi.org/10.66344/jpad.31.4.2021.1738Abstract
Erythema annulare centrifugum (EAC) is an infrequent cutaneous disease characterized by figurate erythematous eruptions that enlarge centrifugally at a rate of 1-3 mm/day with central clearing resulting in an annular or polycyclic appearance. The characteristic skin eruptions of EAC are associated with various underlying systemic disorders, including infections, autoimmune and endocrine diseases, malignancies, and the use of certain drugs like diuretics, non-steroidal anti-inflammatory agents, antimalarials, gold, amitriptyline, finasteride, penicillins, and salicylates, though the causal association has not been established. Lesions usually involve the thighs, legs, and buttocks and are characterized histopathologically by dermal perivascular lymphohistiocytic infiltrate. EAC is a benign self-limited disease. A 64-year-old man with pulmonary nocardiosis, on treatment with co-trimoxazole, presented with peripherally spreading raised red-coloured eruptions over thighs, buttocks, and arms. He developed similar lesions in the past, which resolved spontaneously. Cutaneous examination revealed multiple discrete annular erythematous plaques over flexural areas, thighs and buttocks. Skin biopsy showed coat-sleeve peri-appendageal inflammatory infiltrate in the dermis. Pulmonary nocardiosis was confirmed by positive cultures from broncho-alveolar lavage and PCR. A diagnosis of Erythema Annulare Centrifugum, deep type, possibly associated with nocardiosis and/or co-trimoxazole, was made. The lesions subsided after stopping co-trimoxazole.Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.